Biomaterials to Facilitate Delivery of RNA Agents in Bone Regeneration and Repair

• Published in: ACS biomaterials science & engineering 2017-07, Vol.3 (7), p.1195-1206
• Main Authors: Tsekoura, Eleni K, K.C, Remant Bahadur, Uludag, Hasan
• Format: Article
• Language: English
• ISSN: 2373-9878; 2373-9878
• DOI: 10.1021/acsbiomaterials.6b00387

Bone healing after traumatic injuries or pathological diseases remains an important worldwide problem. In search of safer and more effective approaches to bone regeneration and repair, RNA-based therapeutic agents, specifically microRNAs (miRNAs) and short interfering RNA (siRNA), are beginning to be actively explored. In this review, we summarize current attempts to employ miRNAs and siRNAs in preclinical models of bone repair. We provide a summary of current limitations when attempting to utilize bioactive nucleic acids for therapeutic purposes and position the unique aspects of RNA reagents for clinical bone repair. Delivery strategies for RNA reagents are emphasized and nonviral carriers (biomaterial-based) employed to deliver such reagents are reviewed. Critical features of biomaterial carriers and various delivery technologies centered around nanoparticulate systems are highlighted. We conclude with the authors’ perspectives on the future of the field, outlining main critical issues important to address as RNA reagents are explored for clinical applications.